Gut microbiota are related to Parkinson's disease and clinical phenotype
- PMID: 25476529
- DOI: 10.1002/mds.26069
Gut microbiota are related to Parkinson's disease and clinical phenotype
Abstract
In the course of Parkinson's disease (PD), the enteric nervous system (ENS) and parasympathetic nerves are amongst the structures earliest and most frequently affected by alpha-synuclein pathology. Accordingly, gastrointestinal dysfunction, in particular constipation, is an important non-motor symptom in PD and often precedes the onset of motor symptoms by years. Recent research has shown that intestinal microbiota interact with the autonomic and central nervous system via diverse pathways including the ENS and vagal nerve. The gut microbiome in PD has not been previously investigated. We compared the fecal microbiomes of 72 PD patients and 72 control subjects by pyrosequencing the V1-V3 regions of the bacterial 16S ribosomal RNA gene. Associations between clinical parameters and microbiota were analyzed using generalized linear models, taking into account potential confounders. On average, the abundance of Prevotellaceae in feces of PD patients was reduced by 77.6% as compared with controls. Relative abundance of Prevotellaceae of 6.5% or less had 86.1% sensitivity and 38.9% specificity for PD. A logistic regression classifier based on the abundance of four bacterial families and the severity of constipation identified PD patients with 66.7% sensitivity and 90.3% specificity. The relative abundance of Enterobacteriaceae was positively associated with the severity of postural instability and gait difficulty. These findings suggest that the intestinal microbiome is altered in PD and is related to motor phenotype. Further studies are warranted to elucidate the temporal and causal relationships between gut microbiota and PD and the suitability of the microbiome as a biomarker.
Keywords: biomarker; gastrointestinal dysfunction; gut-brain-axis; microbiome; non-motor symptoms.
© 2014 International Parkinson and Movement Disorder Society.
Comment in
-
Parkinson disease. Gut reactions--can changes in the intestinal microbiome provide new insights into Parkinson disease?Nat Rev Neurol. 2015 Feb;11(2):66. doi: 10.1038/nrneurol.2014.256. Epub 2014 Dec 23. Nat Rev Neurol. 2015. PMID: 25534915 No abstract available.
-
The power in numbers: gut microbiota in Parkinson's disease.Mov Disord. 2015 Mar;30(3):296-8. doi: 10.1002/mds.26116. Epub 2014 Dec 27. Mov Disord. 2015. PMID: 25545262 No abstract available.
-
Provotella-derived hydrogen sulfide, constipation, and neuroprotection in Parkinson's disease.Mov Disord. 2015 Jul;30(8):1151. doi: 10.1002/mds.26258. Epub 2015 May 13. Mov Disord. 2015. PMID: 25970839 No abstract available.
-
Reply to letter to the editor by Assoc. Prof. Yusuf Ozgur Cakmak, MD, PhD.Mov Disord. 2015 Jul;30(8):1151-3. doi: 10.1002/mds.26259. Epub 2015 Jun 22. Mov Disord. 2015. PMID: 26095591 No abstract available.
Similar articles
-
More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.Eur J Neurol. 2017 Nov;24(11):1375-1383. doi: 10.1111/ene.13398. Epub 2017 Sep 11. Eur J Neurol. 2017. PMID: 28891262
-
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.Parkinsonism Relat Disord. 2016 Nov;32:66-72. doi: 10.1016/j.parkreldis.2016.08.019. Epub 2016 Aug 26. Parkinsonism Relat Disord. 2016. PMID: 27591074
-
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.Genome Med. 2017 Apr 28;9(1):39. doi: 10.1186/s13073-017-0428-y. Genome Med. 2017. PMID: 28449715 Free PMC article.
-
Brain-gut-microbiota axis in Parkinson's disease.World J Gastroenterol. 2015 Oct 7;21(37):10609-20. doi: 10.3748/wjg.v21.i37.10609. World J Gastroenterol. 2015. PMID: 26457021 Free PMC article. Review.
-
Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.Int J Mol Sci. 2018 Jun 6;19(6):1689. doi: 10.3390/ijms19061689. Int J Mol Sci. 2018. PMID: 29882798 Free PMC article. Review.
Cited by
-
Parkinson mice show functional and molecular changes in the gut long before motoric disease onset.Mol Neurodegener. 2021 Jun 2;16(1):34. doi: 10.1186/s13024-021-00439-2. Mol Neurodegener. 2021. PMID: 34078425 Free PMC article.
-
Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox.Genome Biol. 2021 Mar 30;22(1):93. doi: 10.1186/s13059-021-02306-1. Genome Biol. 2021. PMID: 33785070 Free PMC article.
-
Microbiota-gut-brain axis in health and neurological disease: Interactions between gut microbiota and the nervous system.J Cell Mol Med. 2024 Sep;28(18):e70099. doi: 10.1111/jcmm.70099. J Cell Mol Med. 2024. PMID: 39300699 Free PMC article. Review.
-
Gut dysbiosis in Huntington's disease: associations among gut microbiota, cognitive performance and clinical outcomes.Brain Commun. 2020 Jul 24;2(2):fcaa110. doi: 10.1093/braincomms/fcaa110. eCollection 2020. Brain Commun. 2020. PMID: 33005892 Free PMC article.
-
Gingipain R1 and Lipopolysaccharide From Porphyromonas gingivalis Have Major Effects on Blood Clot Morphology and Mechanics.Front Immunol. 2020 Jul 24;11:1551. doi: 10.3389/fimmu.2020.01551. eCollection 2020. Front Immunol. 2020. PMID: 32793214 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical